| 37546410 | FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics. | | 2023 |
| 37917078 | Breast Cancer Incidence After a False-Positive Mammography Result. | | 2023 |
| 37996402 | Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation. | Nat Commun | 2023 |
| 37648804 | Influence of mammographic density and compressed breast thickness on true mammographic sensitivity: a cohort study. | | 2023 |
| 37789226 | Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer. | Eur J Epidemiol | 2023 |
| 37338730 | Evaluation of SNPs associated with mammographic density in European women with mammographic density in Asian women from South-East Asia. | Breast Cancer Res Treat | 2023 |
| 37337390 | Novel predictions of invasive breast cancer risk in mammography screening cohorts. | | 2023 |
| 37149701 | Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women. | | 2023 |
| 36901898 | A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31. | | 2023 |
| 36824750 | Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. | Res Sq | 2023 |
| 36765650 | Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Breast Cancer: Evidence from a General Female Population and a Mammographic Screening Cohort in Sweden. | Cancers (Basel) | 2023 |
| 36707629 | FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. | Eur J Hum Genet | 2023 |
| 36637153 | Effects of tamoxifen on normal breast tissue histological composition: Results from a randomised six-arm placebo-controlled trial in healthy women. | | 2023 |
| 37451831 | Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. | J Med Genet | 2023 |
| 37120669 | Clinical biomarker-based biological aging and risk of cancer in the UK Biobank. | | 2023 |
| 36689693 | Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival. | J Clin Oncol | 2023 |
| 37370856 | A Clinical Risk Model for Personalized Screening and Prevention of Breast Cancer. | | 2023 |
| 37243694 | Prediction of breast cancer risk for sisters of women attending screening. | J Natl Cancer Inst | 2023 |
| 36930854 | Long-Term Performance of an Image-Based Short-Term Risk Model for Breast Cancer. | | 2023 |
| 36791753 | Factors Associated With False-Positive Recalls in Mammography Screening. | | 2023 |
| 37296473 | Studying the association between longitudinal mammographic density measurements and breast cancer risk: a joint modelling approach. | | 2023 |
| 36678170 | A Randomized Controlled Trial of Soy Isoflavone Intake on Mammographic Density among Malaysian Women. | | 2023 |
| 37503126 | Understanding the genetic complexity of puberty timing across the allele frequency spectrum. | medRxiv | 2023 |
| 35084436 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes. | JAMA Oncol | 2022 |
| 35526672 | Towards implementation of comprehensive breast cancer risk prediction tools in health care for personalised prevention. | Prev Med | 2022 |
| 36303815 | A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women. | Cancer Res Commun | 2022 |
| 36040641 | Postmenopausal overweight and breast cancer risk; results from the KARMA cohort. | Breast Cancer Research and Treatment | 2022 |
| 35585550 | Breast cancer risks associated with missense variants in breast cancer susceptibility genes. | Genome Med | 2022 |
| 35452252 | Risk Assessment in Population-Based Breast Cancer Screening. | Journal of Clinical Oncology | 2022 |
| 36230723 | External Validation of a Mammography-Derived AI-Based Risk Model in a U.S. Breast Cancer Screening Cohort of White and Black Women. | Cancers | 2022 |
| 35702492 | Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors. | Breast Care (Basel) | 2022 |
| 35648299 | Breast cancer incidence and survival in Scotland by socio-economic deprivation and tumour subtype. | Breast Cancer Res Treat | 2022 |
| 36224404 | Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment. | British Journal of Cancer | 2022 |
| 36162852 | Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study. | J Med Genet | 2022 |
| 36271417 | PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~â¿¿200,000 patients. | Breast Cancer Res | 2022 |
| 35933885 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model. | Eur J Cancer | 2022 |
| 35418701 | Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women. | Sci Rep | 2022 |
| 36328784 | Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. | Br J Sports Med | 2022 |
| 35605013 | Time to Mammographic Density Decrease After Exposure to Tamoxifen. | Oncologist | 2022 |
| 35604960 | Topical Endoxifen for Mammographic Density Reduction-A Randomized Controlled Trial. | Oncologist | 2022 |
| 35544593 | A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care. | Science Translational Medicine | 2022 |
| 35723569 | Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies. | J Natl Cancer Inst | 2022 |
| 36419099 | Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated inâ¿¿~â¿¿200,000 patients. | Breast Cancer Res | 2022 |
| 35042965 | Rare germline copy number variants (CNVs) and breast cancer risk. | Commun Biol | 2022 |
| 35293856 | Risk of heart disease following treatment for breast cancer - results from a population-based cohort study. | Elife | 2022 |
| 35033985 | Circulating proteins reveal prior use of menopausal hormonal therapy and increased risk of breast cancer. | Transl Oncol | 2022 |
| 35267517 | A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16. | Cancers | 2022 |
| 35027432 | Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort. | Cancer Epidemiology Biomarkers and Prevention | 2022 |
| 35026490 | Interval breast cancer is associated with interferon immune response. | Eur J Cancer | 2022 |
| 34438278 | Survival in breast cancer patients with a delayed DIEP flap breast reconstruction after adjustment for socioeconomic status and comorbidity. | Breast | 2021 |